April, 19 2025 Saturday 19:02 Hrs
  • SENSEX :   78,553.20

  • Commodity broking firm in India1,508.91( 1.96%) 17-Apr-2025
top-arrow-market
Sensex 78553.2 1508.91  (1.96) 17-Apr-2025
Previous Day Close
77044.29
Today's High/Low
High Low
  •  
  •  
78616.77 76665.77

Hot Pursuit - Detailed News

Lupin gets EIR from USFDA for Nagpur facility
17-Apr-25   15:00 Hrs IST
The EIR was issued following an inspection of the facility conducted from 10 June to 13 June 2024.

Nilesh Gupta, Managing Director, Lupin, said, 'We are very pleased to have received the EIR from the US FDA for drug-device combination products at our Nagpur injectable facility. We remain committed to producing complex generic and essential products that address unmet needs.

Mumbai-based Lupin is an innovation-led, transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Lupin's consolidated net profit jumped 38.81% to Rs 858.86 crore on a 10.60% increase in sales to Rs 5,618.6 crore in Q3 FY25 compared to Q3 FY24.

Shares of Lupin rose 0.51% to Rs 1,945.65 on the BSE.

Powered by Capital Market - Live News

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.